TP53 and neoplasm: Obad et al. reveal that TRIM22 is a direct target gene for p53, which could be upregulated by p53 and inhibit leukemia U937 cell proliferation and differentiation, suggesting a tumor-suppressive role of TRIM22 in leukemia [24].